🔎 Trials Near Me

Beranda › Obesitas › Alabama › Birmingham

Uji klinis Obesitas di Birmingham, AL

23 studi untuk Obesitas mencari peserta di lokasi sekitar Birmingham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Menerima pesertaFase 3
  • Univ of Alabama Birmingham, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07533175

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Menerima pesertaFase 2
  • University of Alabama - Birmingham, Birmingham
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Menerima pesertaFase 3
  • Univ of Alabama Birmingham, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07720271

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Menerima pesertaFase 3
  • Birmingham Clinical Research, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Menerima pesertaFase 3
  • Birmingham Clinical Research, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07392190

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 3
  • AURORA-1 Clinical Site, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Menerima pesertaFase 3
  • AURORA-2 Clinical Site, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Menerima pesertaFase 3
  • University of Alabama Saint Vincent's Birmingham, Birmingham
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Menerima pesertaFase 3
  • Alabama Clinical Therapeutics, Birmingham
  • University of Alabama at Birmingham, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Menerima pesertaFase 3Sukarelawan sehat diterima
  • ACCOMPLISH-2 Research Site, Birmingham
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Menerima pesertaFase 3
  • Uni of Alabama at Birmingham, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07770841

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Menerima pesertaFase 3
  • Kailera Clinical Site, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284875

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Menerima pesertaFase 3
  • Univ of Alabama Birmingham, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Menerima pesertaFase 3
  • ACCOMPLISH-1 Research Site, Birmingham
  • ACCOMPLISH-1 Research Site, Birmingham
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07654361

Time-restricted Eating for Postpartum Weight Loss

Menerima peserta
  • University of Alabama at Birmingham, Birmingham
Usia 18 ke atas · Wanita · Diperbarui 29 Jun 2026 · NCT06491537

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

Menerima peserta
  • University of Alabama at Birmingham, Birmingham
Usia 18 hingga 45 · Wanita · Diperbarui 24 Jun 2026 · NCT05124808

GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

Menerima pesertaSukarelawan sehat diterima
  • University of Alabama at Birmingham, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT05216042

PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

Menerima pesertaFase 2/3Sukarelawan sehat diterima
  • University of Alabama at Birmingham, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT04971720

Ketogenic Diets for Weight Loss Maintenance: Impact on Energy Expenditure and Appetite in Individuals With Obesity

Menerima peserta
  • University of Alabama at Birmingham, Birmingham
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 7 Apr 2026 · NCT06736028

CARBON: UAB Cardiovascular Research Biobank

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • University of Alabama at Birmingham, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT05067231

FELLAShip to Better Health

Menerima peserta
  • The Worship Center Cristian Church, Birmingham
Usia 18 ke atas · Pria · Diperbarui 22 Jan 2026 · NCT07220213

Inspire HER: Inspiring the Heart and Emotions for Radical Health

Menerima peserta
  • University of Alabama at Birmingham, Birmingham
Usia 30 hingga 79 · Wanita · Diperbarui 29 Des 2025 · NCT06966258

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

Menerima pesertaFase 1/2Sukarelawan sehat diterima
  • UAB Pediatric Endocrinology (Part C and Part D), Birmingham
Usia 12 hingga 65 · Semua jenis kelamin · Diperbarui 22 Des 2025 · NCT06239116

Uji klinis Obesitas di kota lain

Studi lain di Birmingham

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.